Refine
Document Type
- Article (9)
- Doctoral Thesis (1)
Has Fulltext
- yes (10)
Is part of the Bibliography
- no (10)
Keywords
- DMEK (4)
- Fuchs endothelial dystrophy (2)
- Scheimpflug imaging (2)
- Visual quality (2)
- cataract surgery (2)
- corneal edema (2)
- corneal transplantation (2)
- Aniridia (1)
- Aphakia (1)
- Artificial iris (1)
- Autoimmune response (1)
- DSAEK (1)
- ICL (1)
- ICL V4c (1)
- IOL scleral Fixation (1)
- Myopia (1)
- Ocular trauma (1)
- Ocular tuberculosis (1)
- Phakic (1)
- Phlyctenule (1)
- Scrofulous keratitis (1)
- Yamane (1)
- anterior chamber depth changes (1)
- cataract surgery workflow (1)
- clear lens exchange (1)
- effective lens position (1)
- efficiency (1)
- pIOL (1)
- pseudoexfoliative syndrome (1)
- refractive lens exchange (1)
- refractive surgery (1)
- repeat DMEK (1)
- toric intraocular lens (1)
Institute
- Medizin (10)
Purpose: To investigate the efficacy and safety of Descemet membrane endothelial keratoplasty (DMEK) for corneal decompensation following primary Descemet stripping automated endothelial keratoplasty (DSAEK).
Methods: This was a retrospective case series of 15 patients that underwent DMEK surgery for corneal decompensation after failed DSAEK. Main outcome parameter was corrected distance visual acuity (CDVA) after DMEK and DSAEK. Secondary outcome measures included central corneal thickness (CCT), endothelial cell density (ECD), rebubbling rate, and primary graft failure after DMEK. Explanted DSAEK grafts were evaluated by light microscopy.
Results: The mean (±SD) time period between DSAEK and DMEK surgery was 15±8 months (range, 6–31 months). Preoperative CDVA was 1.72±0.62 (logMAR). After DMEK, CDVA improved significantly to 0.78±0.48 at 1 month and to 0.23±0.24 after 12 months (P=0.022). Visual acuity data after DMEK were significantly better compared to preoperative values. The average CCT after DMEK decreased significantly from 869±210 µm (preoperative) to 505±45 µm (1 month postoperative) (P<0.001) and remained stable over 12 months. The ECD decreased from 2,589±209/mm2 (preoperative) to 1,691±589/mm2 (12 months postoperative). Rebubbling DMEK was required in three patients (=20%).
Conclusion: DMEK represents a feasible and safe procedure in achieving better functional results compared to DSAEK. Visual acuity and optical quality can be effectively reestablished after unsuccessful primary DSAEK surgery even in patients with long-standing corneal decompensation. Further investigations are required to validate the preliminary clinical findings.
Purpose: To evaluate if repeat Descemet membrane endothelial keratoplasty (DMEK) is appropriate to achieve functional improvements in patients with corneal decompensation from secondary graft failure after primary DMEK.
Methods: This is a retrospective monocentric cohort study including 13 eyes of 13 patients with repeat DMEK for corneal decompensation following primary DMEK. Eyes with primary DMEK only and comparable preoperative corrected distance visual acuity (CDVA) served as control. Main outcome parameter was CDVA. Secondary outcome measures were central corneal thickness (CCT), endothelial cell density, and rebubbling rate (RR).
Results: The average time interval (±SD) between primary and secondary DMEK was 12.5±6 months. Preoperative CDVA (logMAR) was 1.97±0.90 in the repeat DMEK group and 1.38±0.92 in the primary DMEK group. At 6 months, both groups showed significant improvement in visual acuity (repeat DMEK group, 0.49±0.35, P<0.01 and primary DMEK group, 0.40±0.36, P<0.01). CDVA did not differ significantly between both groups at all time points examined (1, 3, and 6 months postoperatively). Mean CCT values at 3 and 6 months postoperatively did not differ significantly between the two groups (P>0.05). The RR was
23% (n=3) in both groups.
Conclusion: Repeat DMEK is a useful therapeutic approach in the setting of corneal decompensation following primary DMEK. Functional results of repeat DMEK, visual acuity in particular, are comparable to patients with single DMEK only.
Purpose: To report a case of autoimmune keratitis in a patient with mycobacterium tuberculosis (MBT).
Methods: An 84-year-old male with pulmonary tuberculosis (TB) was admitted with chronic, non-healing bilateral ulcerations of the inferior peripheral cornea associated with stromal and subconjunctival nodules.
Results: Clinical examination revealed circumscribed peripheral corneal ulceration with whitish nodules in adjacent stromal and subconjunctival tissue. Microbiological cultures of the corneal tissue were negative for MBT and other microbial pathogens; however, enzyme-linked immunosorbent assay (ELISA) of blood and corneal samples showed significantly elevated levels of IgM and IgA against MBT. In addition to systemic anti-tuberculosis therapy, the patient was treated topically with Polyspectran® eye drops, Dexamethasone eye drops, and Bepanthen® ointment, for 2 weeks. Both eyes showed dramatic improvement after 2 weeks.
Conclusion: The present report demonstrates that MBT is able to initiate delayed autoimmune response within the corneal tissue during an intensive phase of anti-tuberculosis treatment.
Purpose: To describe a novel surgical technique of a combined implantation of an artificial iris and a scleral fixated intraocular lens (IOL) using flanged IOL haptics (“Yamane” technique).
Observations: The suturelessly implanted artificial iris-IOL-sandwich was stable with good functional as well as aesthetic results. However, our case showed a postoperative intraocular pressure rise.
Conclusions: The presented case demonstrates that a visual as well as cosmetical rehabilitation seems to be possible even after severe, penetrating ocular trauma with profound iris defects.
Importance: The sutureless IOL scleral fixation technique can also be used in combination with a sutureless artificial iris implantation. Further studies are needed to evaluate the long-term safety profile and rates of postoperative complications.
Purpose: To evaluate intermediate and long-term visual outcomes and safety of a phakic intraocular posterior chamber lens with a central hole (ICL V4c) for myopic eyes.
Methods: Retrospective, consecutive case study of patients that uneventfully received a ICL V4c for myopia correction, with a 5-year postoperative follow-up. Department of Ophthalmology, Goethe University Frankfurt, Germany.
Results: From 241 eyes that underwent ICL implantation, we included 45 eyes with a mean age at surgery of 33 years ± 6 (18–48 years), with a 5 years follow-up. CDVA improved from 0.05logMAR ± 0.15 CDVA preoperatively to − 0.00 ± 0,07 at 5 years and did not change significantly from 3 to 5 years’ time (p = 0.266). The mean spherical equivalent (SE) improved from -10.13D ± 3.39 to − 0.45D ± 0.69. The change in endothelial cell count showed a mean decrease of 1.9% per year throughout the follow-up. Safety and efficacy index were 1.16 and 0.78, respectively. Cataract formation was seen in 2 of 241 eyes (0.8%), but in none of the 45 eyes that finished the 5-year follow-up.
Conclusions: Our data show a good intermediate and long-term stability, efficiency, and safety of ICL V4c phakic lenses in myopic eyes comparable to other known literature.
Purpose: To investigate short-term (3 months follow-up) changes in visual quality following Descemet membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy (FED). Methods: In this prospective institutional case series, 51 patients that underwent DMEK for FED were included. Assessment included the Quality of Vision (QoV) questionnaire preoperatively, at 1 month, and 3 months after surgery. Secondary outcome measures were anterior segment parameters acquired by Scheimpflug imaging, corrected distance visual acuity (CDVA), and endothelial cell density (ECD). Results: Glare, hazy vision, blurred vision, and daily fluctuation in vision were the symptoms mostly reported preoperatively. All symptoms demonstrated a significant reduction of item scores for severity, frequency, and bothersome in the course after DMEK (P < 0.01). Glare and fluctuation in vision remained to some extent during the follow-up period (median score = 1). Preoperatively, corneal densitometry correlated moderately to weakly with severity of hazy vision (rs = 0.39; P = 0.03) and frequency (rs = 0.26; P = 0.02) as well as severity (rs = 0.27; P = 0.03) of blurry vision. CDVA and central corneal thickness (CCT) did not correlate with visual complains. Conclusions: Following DMEK for FED, patient-reported visual symptoms assessed by the QoV questionnaire represent a useful tool providing valuable information on the impact of DMEK on visual quality that cannot be directly estimated by morphological parameters and visual acuity only.
Purpose: To investigate short-term (3 months follow-up) changes in visual quality following Descemet membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy (FED). Methods: In this prospective institutional case series, 51 patients that underwent DMEK for FED were included. Assessment included the Quality of Vision (QoV) questionnaire preoperatively, at 1 month, and 3 months after surgery. Secondary outcome measures were anterior segment parameters acquired by Scheimpflug imaging, corrected distance visual acuity (CDVA), and endothelial cell density (ECD). Results: Glare, hazy vision, blurred vision, and daily fluctuation in vision were the symptoms mostly reported preoperatively. All symptoms demonstrated a significant reduction of item scores for severity, frequency, and bothersome in the course after DMEK (P < 0.01). Glare and fluctuation in vision remained to some extent during the follow-up period (median score = 1). Preoperatively, corneal densitometry correlated moderately to weakly with severity of hazy vision (rs = 0.39; P = 0.03) and frequency (rs = 0.26; P = 0.02) as well as severity (rs = 0.27; P = 0.03) of blurry vision. CDVA and central corneal thickness (CCT) did not correlate with visual complains. Conclusions: Following DMEK for FED, patient-reported visual symptoms assessed by the QoV questionnaire represent a useful tool providing valuable information on the impact of DMEK on visual quality that cannot be directly estimated by morphological parameters and visual acuity only.
Purpose: To compare the effective lens position (ELP), anterior chamber depth (ACD) changes, and visual outcomes in patients with and without pseudoexfoliation syndrome (PEX) after cataract surgery.
Design: Prospective, randomized, fellow-eye controlled clinical case series.
Methods: This prospective comparative case series enrolled 56 eyes of 56 consecutive patients with (n = 28) or without PEX (n = 28) and clinically significant cataract who underwent standard phacoemulsification and were implanted with single-piece acrylic posterior chamber intraocular lenses (IOLs). The primary outcome parameters were the ACD referring to the distance between the corneal anterior surface and the lens anterior surface, which is an indicator of the postoperative axial position of the IOL (the so-called ELP) and distance corrected visual acuity (DCVA).
Results: Before surgery, the ACD was 2.54 ± 0.42 mm in the PEX group and 2.53 ± 0.38 mm in the control group (p = 0.941). Postoperatively, the ACD was 4.29 ± 0.71 mm in the PEX group and 4.33 ± 0.72 mm in the normal group, respectively (p = 0.533). There was no significant difference in ACD changes between groups (PEX group: 1.75 ± 0.74 mm, control group: 1.81 ± 0.61 mm, p = 0.806) and DCVA pre- (p = 0.469) and postoperatively (PEX group: 0.11 ± 0.13 logMAR, control group: 0.09 ± 0.17 logMAR, p = 0.245) between groups.
Conclusion: Preoperative and postoperative ACD, as an indicator of ELP, between PEX eyes and healthy eyes after cataract surgery showed no significant difference. Phacoemulsification induced similar changes in eyes with PEX compared to healthy eyes.
Background: To determine whether there is a significant saving of time when using a digital cataract workflow for digital data transfer compared to a manual approach of biometry assessment, data export, intraocular lens calculation, and surgery time.
Methods: In total, 48 eyes of 24 patients were divided into two groups: 24 eyes were evaluated using a manual approach, whereas another 24 eyes underwent a full digital lens surgery workflow. The primary variables for comparison between both groups were the overall time as well as several time steps starting at optical biometry acquisition until the end of the surgical lens implantation. Other outcomes, such as toric intraocular lens misalignment, reduction of cylinder, surgically induced astigmatism, prediction error, and distance visual acuity were measured.
Results: Overall, the total diagnostic and surgical time was reduced from 1364.1 ± 202.6 s in the manual group to 1125.8 ± 183.2 s in the digital group (p < 0.001). The complete time of surgery declined from 756.5 ± 82.3 s to 667.3 ± 56.3 (p < 0.0005). Compared to the manual approach of biometric data export and intraocular lens calculation (76.7 ± 12.3 s) as well as the manual export of the reference image to a portable external storage device (26.8 ± 5.5 s), a highly significant saving of time was achieved (p < 0.0001).
Conclusions: Using a software-based digital approach to toric intraocular lens implantation is convenient, more efficient, and thus more economical than a manual workflow in surgery practice.
Zur Korrektur der Myopie bietet die refraktive Chirurgie prinzipiell die Möglichkeiten entweder die Kornea zu modulieren oder eine phake Intraokularlinse einzusetzen. Bei der Beseitigung einer hochgradigen Myopie von über 6 dpt haben sich jedoch die pIOL durchgesetzt. Besonders irisfixierte Linsen weisen sehr gute Refraktionsergebnisse bei einem geringen Komplikationsprofil auf. Zwei Modelle der Artisan-Linse (optische Zone 5 mm n = 48, optische Zone 6 mm n = 264) wurden in 312 Augen von 176 hochgradig myopen Probanden in der Universitätsaugenklinik Frankfurt am Main eingesetzt. Die Untersuchung und Auswertung erfolgte hinsichtlich der Refraktionsqualität und Komplikationsrate. Zur Beurteilung der Refraktion wurden die Standardparameter der refraktiven Chirurgie (Sicherheit, Wirksamkeit, Vorhersagbarkeit und Stabilität) gemessen und analysiert. Bei Erhebung und Analyse des Komplikationsprofils wurde besonderes Augenmerk auf den Verlust der EZD gerichtet. Die Untersuchungen wurden präoperativ, nach einem Tag, einer Woche, einem Monat und anschließend im Jahresrhythmus durchgeführt. Der präoperative mittlere BKSM von 0,82 wurde bei keiner Folgeuntersuchung unterschritten, so dass der Sicherheitsindex stets über 1 betrug. Kein Patient verlor mehr als eine Zeile beim BKSM. Ein UKSM von 0,8 oder mehr wurde nach einem Jahr in 78%, nach zwei Jahren in 81%, nach drei Jahren in 76%, nach vier Jahren in 60% und nach fünf Jahren in 65% der Fälle beobachtet. Im Vergleich dazu betrug der präoperative BKSM bei 78% der Augen 0,8 oder mehr. Die Vorhersagbarkeit erwies sich innerhalb des gesamten Beobachtungszeitraums als sehr hoch. Bei vier der fünf Jahreskontrollen lagen alle Augen (98% bei der 3-Jahresuntersuchung) innerhalb einer Spannweite von ± 2 dpt und stets mindestens 86% der Augen innerhalb von ± 1 dpt der angestrebten refraktiven Korrektur. Das mittlere sphärische Äquivalent betrug präoperativ -11,24 ±4,46 dpt. Einen Monat nach der Implantation der irisfixierten Linse ergab sich ein Wert von -0,54 ±0,55 dpt. Es kam zu keinen größeren Veränderungen der Refraktion während des Nachbeobachtungszeitraums (Minimum: -0,78 dpt nach fünf Jahren; Maximum: -0,41 dpt nach einem Jahr). Im Mittel betrug die präoperative Endothelzellzahl 2751 ±331 Zellen/mm2 (2004 bis 3508) und verringerte sich durchschnittlich um 2,6% / Jahr auf 2387 ±322 Zellen/mm2 (1605 bis 3164) nach fünf Jahren. Bei Auswertung der EZD der konsekutiven Kohorte wurde an zwei Augen ein Verlust von über 30% registriert (34% bzw. 38%). An keinem Auge wurde ein intrastromales Korneaödem oder eine Trübung der Hornhaut festgestellt. Eine signifikante Assoziation zwischen Pigmentdispersion und erhöhtem intraokularem Druck konnte beobachtet werden (p = 0,047). Schwere Nebenwirkungen wie eine chronische Entzündung oder Glaukom sind nicht aufgetreten. An 9 Augen mußte eine Reenklavation erfolgen, ursächlich hierfür war in einem Fall eine Dezentrierung, in einem anderen eine Iritis und in den übrigen Fällen zu wenig eingehaktes Irisgewebe in den Linsenhaptiken. Eine Explantation war an keinem Auge indiziert. Um ein besseres Refraktionsergebnis zu erzielen, wurde in 21 Augen mittels LASIK und in 9 Augen mittels LRI nachkorrigiert. Diese Langzeitergebnisse der irisfixierten Linse zur Korrektur einer hochgradigen Myopie erweisen sich hinsichtlich Sicherheit, Wirksamkeit, Vorhersagbarkeit und Stabilität als sehr gut. Im Vergleich zum natürlichen Verlust der EZD ist dieser nach Einsatz der pIOL signifikant erhöht, so dass bei jüngeren Patienten strengere Ausschlusskriterien eingeführt werden sollten. Insgesamt erweist sich aber die irisfixierte Linse als eine sehr sichere und komplikationsarme Option zur Beseitigung einer hochgradigen Myopie.